In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

International investors find Chinese secondary PE market an alternative amid U.S.-China tensions; QuantumPharm is the first IPO under Hong Kong's new measure for pre-revenue specialist technology firms; and China releases new carbon measuring standards foreseeing new EU carbon tariffs.

6 minute readJune 11, 2024 at 12:24 PM

Krista Lee

In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

✓ A database of 3000+ essential documents, including key PRC laws translated into English
✓ Newsletters with business-critical and sector-specific updates
✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)